Cartalax Peptide: The Complete Guide - Uses, Mechanism, Dosing, Safety & Research
Cartalax is a synthetic tripeptide bioregulator composed of three amino acids - alanine, glutamic acid, and aspartic acid (sequence abbreviated AED) - developed as part of the Khavinson short bioregulatory peptide research program in Russia. It works through a mechanism that is genuinely unusual among research peptides: rather than binding to cell surface receptors, it penetrates directly into cell nuclei and interacts with DNA to modulate gene expression in tissues including cartilage, skin, and kidney. This guide covers what Cartalax does, how it works, what the preclinical research shows, dosing context from animal studies, its safety profile, and its current regulatory status.
